A recent study published in JAMA compared the effectiveness of two medications, methadone and buprenorphine/naloxone, for treating opioid use disorder, revealing that patients treated with methadone had a lower rate of treatment discontinuation over 24 months.
A recent study assessed the safety and efficacy of a wireless communication system between a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator in patients at risk for sudden cardiac death due to ventricular arrhythmias.
A recent study revealed associations between cardiometabolic index (CMI), insulin resistance (IR), prediabetes (preDM), and type 2 diabetes mellitus (T2D) in U.S. adults, showing elevated CMI is linked to a higher likelihood of developing IR, preDM, and T2D, with a plateau effect suggesting maintaining CMI at certain levels is beneficial.
Despite treating older, sicker patients and performing more non-elective surgeries, osteopathic surgeons achieved comparable 30-day mortality rates to their allopathic counterparts, with no significant differences in readmissions or length of stay.
Recent study finds that 84% of adults with congenital heart disease reported good or better quality of life, with notable findings on physical activity and mental health.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Unrestricted hs-cTnT reporting boosted ED discharge rates by 16% while cutting hospital stays, all without increasing myocardial infarctions or invasive procedures.
A recent study reveals that pregnant patients with hidradenitis suppurativa (HS) face significantly higher risks of pregnancy complications and adverse maternal and offspring outcomes, including gestational diabetes and hypertensive disorders.
Electronic nudges boosted flu vaccination rates by up to 13.9 percentage points in chronic disease patients, with the most effective reminder doubling the control group’s rate.
A recent study explores the impact of the COVID-19 pandemic on cancer detection in the U.S., revealing a significant drop in 2020 with certain subgroups still experiencing lower detection rates by 2021.